Condition: Oligometastatic Disease · Metastatic Non Small Cell Lung Cancer · Sponsor: Tata Memorial Hospital
Standard Maintenance Therapy versus Local Consolidative Radiation Therapy and standard maintenance therapy in 1-5 sites of OligoMetastatic Non-small cell lung cancer (NSCLC): A Phase III Randomized Controlled Trial
This description comes directly from the study's public registry record.
Dr. Anil Tibdewal · +91-22-24177000 · aniltibdewal@gmail.com
Dr. Jai Prakash Agarwal · +91-22-24177000 · agarwaljp@tmc.gov.in
Always discuss trial participation with your own doctor first.
| Tata Memorial Hospital, Parel | Mumbai, Maharashtra, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05278052